Veru (VERU) Stock Forecast, Price Target & Predictions
VERU Stock Forecast
Veru stock forecast is as follows: an average price target of $4.00 (represents a 518.24% upside from VERU’s last price of $0.65) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
VERU Price Target
VERU Analyst Ratings
Buy
Veru Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
May 03, 2024 | Yi Chen | H.C. Wainwright | $3.00 | $1.67 | 79.64% | 363.68% |
Apr 15, 2024 | Leland Gershell | Oppenheimer | $5.00 | $1.52 | 228.95% | 672.80% |
Dec 07, 2022 | H.C. Wainwright | $18.00 | $5.66 | 218.02% | 2682.07% | |
Apr 15, 2022 | Leland Gershell | Oppenheimer | $36.00 | $14.95 | 140.80% | 5464.14% |
Veru Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 2 |
Avg Price Target | - | - | $4.00 |
Last Closing Price | $0.65 | $0.65 | $0.65 |
Upside/Downside | -100.00% | -100.00% | 518.24% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
May 14, 2024 | B. Riley | Buy | Initialise | |
May 06, 2024 | Raymond James | Buy | Buy | Hold |
May 03, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Apr 15, 2024 | Oppenheimer | Outperform | Outperform | Hold |
Jun 07, 2023 | Jefferies | Buy | Hold | Upgrade |
Dec 05, 2022 | Cantor Fitzgerald | Overweight | Overweight | Hold |
Jul 11, 2022 | Oppenheimer | Outperform | Outperform | Hold |
Jul 06, 2022 | Jefferies | Buy | Buy | Hold |
May 13, 2022 | Oppenheimer | Outperform | Outperform | Hold |
May 13, 2022 | Jefferies | Buy | Buy | Hold |
Apr 26, 2022 | Zacks Investment Research | Hold | Downgrade | |
Apr 14, 2022 | Oppenheimer | Outperform | Outperform | Hold |
Veru Financial Forecast
Veru Revenue Forecast
Quarter
Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | $2.14M | $3.86M | $3.34M | $6.59M | $2.51M | $2.59M | $9.60M | $13.03M | $14.14M | $15.65M | $17.66M | $13.34M | $14.62M | $11.75M | $10.32M | $9.94M | $10.58M | $8.73M | $9.73M | $6.98M |
Avg Forecast | $1.70M | $1.90M | $2.10M | $3.50M | $3.50M | $3.50M | $3.50M | $3.56M | $3.50M | $3.00M | $3.90M | $3.95M | $6.21M | $4.33M | $5.07M | $11.55M | $16.67M | $12.21M | $13.84M | $18.17M | $14.10M | $14.29M | $10.92M | $10.61M | $10.74M | $10.97M | $8.77M | $9.17M | $8.06M | $6.86M |
High Forecast | $1.90M | $2.12M | $2.34M | $3.90M | $3.90M | $3.95M | $3.86M | $4.30M | $3.90M | $3.35M | $5.90M | $4.41M | $6.93M | $4.82M | $5.65M | $11.55M | $16.67M | $12.21M | $13.84M | $18.17M | $14.10M | $14.29M | $10.92M | $10.61M | $10.74M | $10.97M | $8.77M | $9.17M | $8.06M | $6.86M |
Low Forecast | $1.60M | $1.79M | $1.97M | $3.29M | $3.29M | $3.27M | $3.31M | $3.00M | $3.29M | $2.82M | $1.90M | $3.71M | $5.84M | $4.07M | $4.76M | $11.55M | $16.67M | $12.21M | $13.84M | $18.17M | $14.10M | $14.29M | $10.92M | $10.61M | $10.74M | $10.97M | $8.77M | $9.17M | $8.06M | $6.86M |
# Analysts | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 5 | 4 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
Surprise % | - | - | - | - | - | - | - | - | - | - | 0.55% | 0.98% | 0.54% | 1.52% | 0.49% | 0.22% | 0.58% | 1.07% | 1.02% | 0.86% | 1.25% | 0.93% | 1.34% | 1.11% | 0.96% | 0.91% | 1.21% | 0.95% | 1.21% | 1.02% |
Forecast
Veru EBITDA Forecast
Quarter
Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 5 | 4 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
EBITDA | - | - | - | - | - | - | - | - | - | - | $-8.80M | $-11.84M | $4.86M | $-31.62M | $-35.59M | $-44.67M | $-21.70M | $-11.72M | $-4.85M | $-1.81M | $-2.87M | $-1.49M | $767.35K | $2.88M | $-1.33M | $-131.91K | $-1.66M | $-1.32M | $-1.70M | $-1.98M |
Avg Forecast | $-819.21K | $-915.58K | $-1.01M | $-1.69M | $-1.69M | $-1.69M | $-1.69M | $-1.72M | $-1.69M | $-1.45M | $-1.88M | $-1.90M | $-2.99M | $-2.08M | $-2.44M | $-6.79M | $-9.79M | $-1.70M | $-8.13M | $-10.67M | $-8.29M | $-1.54M | $-6.42M | $-6.23M | $-6.31M | $530.91K | $-5.15M | $-5.39M | $-4.73M | $-2.63M |
High Forecast | $-770.25K | $-860.87K | $-951.49K | $-1.59M | $-1.59M | $-1.58M | $-1.59M | $-1.45M | $-1.59M | $-1.36M | $-917.83K | $-1.79M | $-2.82M | $-1.96M | $-2.30M | $-6.79M | $-9.79M | $-1.36M | $-8.13M | $-10.67M | $-8.29M | $-1.24M | $-6.42M | $-6.23M | $-6.31M | $637.09K | $-5.15M | $-5.39M | $-4.73M | $-2.11M |
Low Forecast | $-913.86K | $-1.02M | $-1.13M | $-1.88M | $-1.88M | $-1.90M | $-1.86M | $-2.07M | $-1.88M | $-1.61M | $-2.84M | $-2.12M | $-3.34M | $-2.32M | $-2.72M | $-6.79M | $-9.79M | $-2.04M | $-8.13M | $-10.67M | $-8.29M | $-1.85M | $-6.42M | $-6.23M | $-6.31M | $424.73K | $-5.15M | $-5.39M | $-4.73M | $-3.16M |
Surprise % | - | - | - | - | - | - | - | - | - | - | 4.68% | 6.22% | -1.62% | 15.17% | 14.58% | 6.58% | 2.22% | 6.89% | 0.60% | 0.17% | 0.35% | 0.97% | -0.12% | -0.46% | 0.21% | -0.25% | 0.32% | 0.25% | 0.36% | 0.75% |
Forecast
Veru Net Income Forecast
Quarter
Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 5 | 4 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
Net Income | - | - | - | - | - | - | - | - | - | - | $-8.28M | $-23.77M | $6.31M | $-38.79M | $-36.84M | $-41.02M | $-22.20M | $-14.18M | $-6.38M | $-4.29M | $-2.69M | $-2.85M | $17.23M | $-11.83M | $-3.03M | $-810.51K | $-3.31M | $-3.06M | $-2.77M | $-4.03M |
Avg Forecast | $-14.64M | $-13.17M | $-11.71M | $-10.25M | $-10.25M | $-10.25M | $-10.25M | $-12.42M | $-8.49M | $-7.81M | $-17.57M | $-34.40M | $-29.76M | $-48.67M | $-55.14M | $-44.28M | $-23.42M | $-3.13M | $-13.76M | $-13.47M | $-8.78M | $-2.85M | $-6.95M | $-5.37M | $-4.76M | $-1.28M | $-3.42M | $-7.32M | $-6.34M | $-4.03M |
High Forecast | $-13.50M | $-12.15M | $-10.80M | $-9.45M | $-9.45M | $-9.45M | $-9.45M | $-12.38M | $-7.83M | $-7.20M | $-10.81M | $-31.73M | $-27.45M | $-44.89M | $-50.85M | $-44.28M | $-23.42M | $-2.50M | $-13.76M | $-13.47M | $-8.78M | $-2.28M | $-6.95M | $-5.37M | $-4.76M | $-1.02M | $-3.42M | $-7.32M | $-6.34M | $-3.23M |
Low Forecast | $-16.84M | $-15.15M | $-13.47M | $-11.79M | $-11.79M | $-11.79M | $-11.79M | $-12.46M | $-9.77M | $-8.98M | $-20.27M | $-39.57M | $-34.23M | $-55.98M | $-63.42M | $-44.28M | $-23.42M | $-3.76M | $-13.76M | $-13.47M | $-8.78M | $-3.42M | $-6.95M | $-5.37M | $-4.76M | $-1.53M | $-3.42M | $-7.32M | $-6.34M | $-4.84M |
Surprise % | - | - | - | - | - | - | - | - | - | - | 0.47% | 0.69% | -0.21% | 0.80% | 0.67% | 0.93% | 0.95% | 4.53% | 0.46% | 0.32% | 0.31% | 1.00% | -2.48% | 2.20% | 0.64% | 0.63% | 0.97% | 0.42% | 0.44% | 1.00% |
Forecast
Veru SG&A Forecast
Quarter
Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 5 | 4 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
SG&A | - | - | - | - | - | - | - | - | - | - | $8.30M | $6.77M | $10.90M | $12.83M | $17.55M | $18.29M | $10.76M | $7.40M | $6.72M | $5.92M | $5.56M | $4.81M | $4.38M | $3.46M | $3.48M | $3.81M | $3.75M | $3.69M | $3.55M | $3.82M |
Avg Forecast | $1.76M | $1.97M | $2.17M | $3.62M | $3.62M | $3.62M | $3.62M | $3.68M | $3.62M | $3.10M | $4.04M | $4.09M | $6.43M | $4.48M | $5.24M | $11.95M | $17.25M | $5.29M | $14.33M | $18.80M | $14.59M | $4.81M | $11.30M | $10.98M | $11.11M | $5.99M | $9.07M | $9.49M | $8.34M | $3.82M |
High Forecast | $1.96M | $2.19M | $2.42M | $4.04M | $4.04M | $4.09M | $3.99M | $4.45M | $4.04M | $3.46M | $6.10M | $4.56M | $7.18M | $4.99M | $5.85M | $11.95M | $17.25M | $6.35M | $14.33M | $18.80M | $14.59M | $5.77M | $11.30M | $10.98M | $11.11M | $7.19M | $9.07M | $9.49M | $8.34M | $4.59M |
Low Forecast | $1.65M | $1.85M | $2.04M | $3.41M | $3.41M | $3.39M | $3.42M | $3.10M | $3.41M | $2.92M | $1.97M | $3.84M | $6.05M | $4.21M | $4.93M | $11.95M | $17.25M | $4.23M | $14.33M | $18.80M | $14.59M | $3.85M | $11.30M | $10.98M | $11.11M | $4.80M | $9.07M | $9.49M | $8.34M | $3.06M |
Surprise % | - | - | - | - | - | - | - | - | - | - | 2.06% | 1.66% | 1.70% | 2.87% | 3.35% | 1.53% | 0.62% | 1.40% | 0.47% | 0.32% | 0.38% | 1.00% | 0.39% | 0.32% | 0.31% | 0.63% | 0.41% | 0.39% | 0.43% | 1.00% |
Forecast
Veru EPS Forecast
Quarter
Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 5 | 4 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
EPS | - | - | - | - | - | - | - | - | - | - | $-0.08 | $-0.28 | $0.07 | $-0.48 | $-0.46 | $-0.51 | $-0.28 | $-0.18 | $-0.08 | $-0.05 | $-0.03 | $-0.04 | $0.25 | $-0.17 | $-0.05 | $-0.01 | $-0.05 | $-0.05 | $-0.04 | $-0.06 |
Avg Forecast | $-0.10 | $-0.09 | $-0.08 | $-0.07 | $-0.07 | $-0.07 | $-0.07 | $-0.08 | $-0.06 | $-0.05 | $-0.12 | $-0.23 | $-0.20 | $-0.33 | $-0.38 | $-0.30 | $-0.16 | $-0.14 | $-0.09 | $-0.09 | $-0.06 | $-0.04 | $-0.05 | $-0.04 | $-0.03 | $-0.04 | $-0.02 | $-0.05 | $-0.04 | $-0.06 |
High Forecast | $-0.09 | $-0.08 | $-0.07 | $-0.06 | $-0.06 | $-0.06 | $-0.06 | $-0.08 | $-0.05 | $-0.05 | $-0.07 | $-0.22 | $-0.19 | $-0.31 | $-0.35 | $-0.30 | $-0.16 | $-0.14 | $-0.09 | $-0.09 | $-0.06 | $-0.04 | $-0.05 | $-0.04 | $-0.03 | $-0.04 | $-0.02 | $-0.05 | $-0.04 | $-0.06 |
Low Forecast | $-0.12 | $-0.10 | $-0.09 | $-0.08 | $-0.08 | $-0.08 | $-0.08 | $-0.09 | $-0.07 | $-0.06 | $-0.14 | $-0.27 | $-0.23 | $-0.38 | $-0.43 | $-0.30 | $-0.16 | $-0.14 | $-0.09 | $-0.09 | $-0.06 | $-0.04 | $-0.05 | $-0.04 | $-0.03 | $-0.04 | $-0.02 | $-0.05 | $-0.04 | $-0.06 |
Surprise % | - | - | - | - | - | - | - | - | - | - | 0.69% | 1.19% | -0.35% | 1.44% | 1.22% | 1.69% | 1.75% | 1.27% | 0.85% | 0.58% | 0.56% | 1.00% | -5.26% | 4.64% | 1.39% | 0.29% | 2.18% | 0.94% | 1.02% | 1.12% |
Forecast
Veru Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
LXRX | Lexicon Pharmaceuticals | $0.73 | $6.00 | 721.92% | Buy |
VERU | Veru | $0.71 | $4.00 | 463.38% | Buy |
ANVS | Annovis Bio | $5.11 | $25.50 | 399.02% | Buy |
NVAX | Novavax | $9.00 | $20.33 | 125.89% | Buy |
IOVA | Iovance Biotherapeutics | $7.81 | $12.40 | 58.77% | Buy |
SRPT | Sarepta Therapeutics | $125.76 | $187.20 | 48.85% | Buy |
AXSM | Axsome Therapeutics | $93.51 | $133.00 | 42.23% | Buy |
MCRB | Seres Therapeutics | $0.88 | $1.25 | 42.05% | Buy |
AVXL | Anavex Life Sciences | $9.21 | $11.00 | 19.44% | Buy |
TSVT | 2seventy bio | $3.21 | $2.00 | -37.69% | Buy |